• Sulfo-NHS-LC-Biotin: Practical Protocol Guide

  2026-08-23

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact-cell surfaces. It is appropriate for stable detection, capture, or purification with avidin or streptavidin systems, but not for reversible labeling or intracellular labeling of cells with an intact plasma membrane.

• CCG-1423 RhoA Inhibitor: Workflow & Applications

  2026-08-22

  CCG-1423 is a pathway-focused RhoA inhibitor for separating MRTF-A nuclear signaling from actomyosin contractility. This article presents practical workflows for cancer research, apoptosis assays, invasion studies, and carefully controlled exploratory work on RhoA/ROCK-dependent barrier biology.

• Coumestrol for RA and ER Signaling Research

  2026-08-22

  Coumestrol is a phytoestrogen estrogen receptor antagonist that supports both rheumatoid arthritis fibroblast-like synoviocyte studies and broader nuclear receptor assays. Its value lies in pairing estrogen receptor pharmacology with a reference-supported PMAIP1, mitochondrial stress, and ferroptosis workflow.

• Catalpol in Cardio-Cerebrovascular Protection

  2026-08-21

  This comprehensive review maps how catalpol, an iridoid glucoside from Rehmannia glutinosa, may protect the heart and cerebrovascular system through antioxidant, anti-inflammatory, anti-apoptotic, and mitochondrial mechanisms. Its main practical contribution is an integrated framework connecting disease models, signaling pathways, pharmacokinetics, analytical control, and translational limitations.

• Cycloheximide in Apoptosis Mechanism Studies

  2026-08-20

  Cycloheximide is a powerful protein biosynthesis inhibitor for separating translation-dependent signaling from protein decay. This article explains how to use it to interpret Ku70 ubiquitination, mitochondrial remodeling, apoptosis, and protein turnover without confusing translational arrest with mechanism.

• Sulfo-NHS-LC-Biotin Protocol and QC Guide

  2026-08-20

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of primary amines on proteins, peptides, and intact cell-surface proteins. It is suited to streptavidin-based detection, capture, and purification, but not to intracellular labeling or workflows that require reversible modification.

• NHS-Biotin for Protein Detection and Purification

  2026-08-19

  NHS-Biotin enables covalent, low-steric-hindrance labeling of antibodies, proteins, and intracellular targets for streptavidin-based detection or purification. This guide connects a practical amine-labeling workflow with peptidisc-assisted nanobody clustering, while separating established product use from emerging assay extensions.

• Itraconazole as a Biofilm Resistance Probe

  2026-08-19

  Itraconazole is more than a triazole antifungal agent: it can function as a controlled perturbation in Candida biofilm and resistance research. This article translates PP2A–autophagy findings into practical assay decisions while distinguishing antifungal, CYP3A4, hedgehog, and angiogenesis applications.

• Bradford Protein Assay Kit: Practical Workflow

  2026-08-18

  The Bradford Protein Assay Kit (SKU K4103) provides rapid protein concentration measurement for soluble samples used in enzyme assays, purification, and molecular biology. It is best used with compatible, low-interference matrices and should be avoided for high-detergent samples or peptides with insufficient basic or aromatic residues.

• A 83-01 (ALK Inhibitor) for Organoid Research

  2026-08-18

  A 83-01 enables controlled TGF-β pathway perturbation in EMT, fibrosis, growth-inhibition, and intestinal organoid assays. Its value is greatest when paired with hiPSC-derived intestinal models that separate 3D expansion from 2D pharmacokinetic testing.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-08-17

  Track where an mRNA formulation goes with Cy5, then measure whether it produces functional protein with Firefly Luciferase. This dual-readout design helps separate delivery, intracellular persistence, and translation in transfection, carrier-screening, and imaging studies.

• 3-Bromopyruvate Reverses Cetuximab Resistance in CRC

  2026-08-17

  The reference study shows that combining 3-bromopyruvate with cetuximab can suppress colorectal cancer models that are intrinsically or adaptively cetuximab-resistant. Its central mechanistic contribution is the connection of FOXO3a restoration with AMPKα–Beclin1 signaling, PUMA activation, autophagy-dependent ferroptosis, and apoptosis.

• Z-IETD-FMK in Reliable Cell Death Assays

  2026-08-16

  Learn how Z-IETD-FMK (SKU B3232) can help researchers separate caspase-8-dependent apoptosis from general loss of viability, immune-cell activation effects, and downstream pyroptotic signaling. This scenario-based guide covers assay controls, stock preparation, interpretation, and practical product-selection criteria.

• Dexamethasone (DHAP) in Translational Inflammation

  2026-08-15

  Dexamethasone (DHAP) is more than a broad anti-inflammatory control: it can function as a mechanistic anchor across NF-κB signaling, stem cell differentiation, autophagy, osteosarcoma, and neuroinflammation workflows. This article connects recent rosemary-root natural-product findings with practical strategies for using a defined glucocorticoid anti-inflammatory in translational research.

• RP3-340N1.2, IL-6, and NSCLC Progression

  2026-08-14

  This study identifies the long non-coding RNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. By combining RNA sequencing, gene-perturbation experiments, RNA decay analysis, RNA immunoprecipitation, and tumor–macrophage co-culture, the authors connect RP3-340N1.2 to malignant behavior and microenvironmental signaling.

8680 records 1/579 page Next 12345 下5页 Last page